FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041198937> ?p ?o ?g. }

• W2041198937 endingPage "490" @default.
• W2041198937 startingPage "486" @default.
• W2041198937 abstract "No AccessJournal of UrologyClinical Urology: Original Articles1 Feb 1999SEXUAL FUNCTION FOLLOWING HIGH ENERGY MICROWAVE THERMOTHERAPY: RESULTS OF A RANDOMIZED CONTROLLED STUDY COMPARING TRANSURETHRAL MICROWAVE THERMOTHERAPY TO TRANSURETHRAL PROSTATIC RESECTION E.A.E. FRANCISCA, F.C.H. d'ANCONA, E.J.H. MEULEMAN, F.M.J. DEBRUYNE, and J.J.M.C.H. de la ROSETTE E.A.E. FRANCISCAE.A.E. FRANCISCA More articles by this author , F.C.H. d'ANCONAF.C.H. d'ANCONA More articles by this author , E.J.H. MEULEMANE.J.H. MEULEMAN More articles by this author , F.M.J. DEBRUYNEF.M.J. DEBRUYNE More articles by this author , and J.J.M.C.H. de la ROSETTEJ.J.M.C.H. de la ROSETTE More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)61930-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We evaluate changes in sexual function in patients treated with high energy transurethral microwave thermotherapy compared to transurethral resection of the prostate. Materials and Methods: A total of 147 patients randomized to undergo transurethral microwave thermotherapy or transurethral resection of the prostate were asked to complete a self-administered questionnaire evaluating sexual function before, and 3 and 12 months after treatment. The questionnaire dealt with such items as social status, libido, quality of erection, ejaculation and overall satisfaction of sexual functioning. Results: There was a statistically significant improvement of micturition in both groups. The improvement in the transurethral prostatic resection group was significantly better than in the transurethral microwave thermotherapy group. Antegrade ejaculation occurred at 3 months following treatment in 27% of the transurethral prostatic resection group compared to 74% of the transurethral microwave thermotherapy group and at 1 year in 37 and 67%, respectively. Significantly more patients undergoing transurethral prostatic resection (36%) had changes in sexual function compared to the transurethral microwave thermotherapy group (17%). The transurethral microwave thermotherapy group was more satisfied with the sex life. Of these patients 55% graded sex as very satisfying compared to 21% in the transurethral prostatic resection group. The severity of symptoms was not correlated with sexual function in this study. In general, older patients had sexual dysfunction more often, while younger patients had pain during sexual activities more frequently. Conclusions: Although clinically less effective, high energy transurethral microwave thermotherapy is a better therapeutic option than surgery for patients who want to preserve sexual function. In particular ejaculation is often preserved after transurethral microwave thermotherapy while there is significant deterioration following transurethral prostatic resection. In general, older patients have greater sexual dysfunction. References 1 : Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT Study). Canad. Med. Assn. J.1996; 155: 1251. Google Scholar 2 : The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate1992; 21: 297. Google Scholar 3 : Current status of thermotherapy of the prostate. J. Urol.1997; 157: 430. Link, Google Scholar 4 : Transurethral microwave heating of the prostate-or from hyperthermia to thermotherapy. J. Endourol.1991; 5: 129. Google Scholar 5 : Heat and lasers for the treatment of BPH: guidance for clinical investigations of devices used for the treatment of benign prostatic hyperplasia. J. Urol.1993; 150: 1588. Abstract, Google Scholar 6 : Transurethral needle ablation of the prostate; a new treatment of benign prostatic hyperplasia using low-level radiofrequency energy. Curr. Opin. Urol.1995; 5: 35. Google Scholar 7 : The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives. J. Urol.1997; 158: 105. Link, Google Scholar 8 : Sexuality and aging. Urol. Clin. N. Amer.1995; 22: 711. Google Scholar 9 : Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-upp. Brit. J. Urol.1995; 76: 614. Google Scholar 10 : The National Prostatectomy Audit. Brit. J. Urol.1997; 79: 69. Google Scholar 11 : Erectile function following transurethral prostatectomy. Brit. J. Urol.1995; 75: 12. Google Scholar 12 : Sexual dysfunction after prostatectomy. Brit. J. Urol.1986; 58: 319. Google Scholar 13 : Single-session transurethral microwave thermotherapy for the treatment of benign prostatic obstruction. J Endourol.1991; 5: 137. Google Scholar 14 : Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet1993; 341: 14. Google Scholar 15 : Quality of life assessment in patients with lower energy thermotherapy: results of a randomized transurethral microwave thermotherapy versus sham study. J. Urol.1997; 158: 1839. Abstract, Google Scholar 16 : Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron cooperative study. J. Urol.1993; 150: 1591. Link, Google Scholar 17 : Ejaculatory dysfunction after transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia. J. Endourol.1994; 8: 217. Google Scholar 18 : Long-term results of lower energy transurethral microwave thermotherapy. J. Urol.1997; 159: 1966. Google Scholar 19 : Transurethral microwave thermotherapy for benign prostatic hyperplasia: clinical outcome after 4 years. J. Urol.1998; 159: 459. Abstract, Google Scholar 20 : High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European benign prostatic hyperplasia study group. J. Urol.1996; 156: 97. Link, Google Scholar 21 : Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J. Urol.1989; 141: 243. Abstract, Google Scholar 22 : Potency and prostatectomy. Brit. J. Urol.1977; 49: 683. Google Scholar 23 : High-energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruction. Urology1996; 48: 416. Google Scholar 24 : Review: transurethral microwave thermotherapy: an evolving technology in the treatment of benign prostatic enlargement. Brit. J. Urol.1995; 76: 531. Google Scholar 25 : Written consent about sexual function in men undergoing transurethral prostatectomy. Brit. J. Urol.1994; 74: 479. Google Scholar 26 : Sexuality in the elderly. Urol. Clin. N. Amer.1996; 23: 99. Google Scholar 27 : The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the International Prostate Symptom Score. J. Urol.1996; 156: 1020. Google Scholar 28 : Relative importance of sexuality and quality of life in patients with prostatic symptoms. Eur. Urol.1997; 31: 272. Google Scholar 29 : The relationship between sexual life and urinary condition in the French community. J. Clin. Epidemiol1996; 49: 1171. Google Scholar From the Department of Urology, University Hospital Nijmegen, Nijmegen, The Netherlands(de la ROSETTE) Financial and/or other relationship with BSC and Bard.© 1999 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byWALMSLEY K and KAPLAN S (2018) TRANSURETHRAL MICROWAVE THERMOTHERAPY FOR BENIGN PROSTATE HYPERPLASIA: SEPARATING TRUTH FROM MARKETING HYPEJournal of Urology, VOL. 172, NO. 4 Part 1, (1249-1255), Online publication date: 1-Oct-2004.MALEK R, KUNTZMAN R and BARRETT D (2018) HIGH POWER POTASSIUM-TITANYL-PHOSPHATE LASER VAPORIZATION PROSTATECTOMYJournal of Urology, VOL. 163, NO. 6, (1730-1733), Online publication date: 1-Jun-2000. Volume 161Issue 2February 1999Page: 486-490 Advertisement Copyright & Permissions© 1999 by American Urological Association, Inc.MetricsAuthor Information E.A.E. FRANCISCA More articles by this author F.C.H. d'ANCONA More articles by this author E.J.H. MEULEMAN More articles by this author F.M.J. DEBRUYNE More articles by this author J.J.M.C.H. de la ROSETTE More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2041198937 created "2016-06-24" @default.
• W2041198937 creator A5009372114 @default.
• W2041198937 creator A5024919772 @default.
• W2041198937 creator A5025890613 @default.
• W2041198937 creator A5082495905 @default.
• W2041198937 creator A5089739371 @default.
• W2041198937 date "1999-02-01" @default.
• W2041198937 modified "2023-09-27" @default.
• W2041198937 title "SEXUAL FUNCTION FOLLOWING HIGH ENERGY MICROWAVE THERMOTHERAPY: RESULTS OF A RANDOMIZED CONTROLLED STUDY COMPARING TRANSURETHRAL MICROWAVE THERMOTHERAPY TO TRANSURETHRAL PROSTATIC RESECTION" @default.
• W2041198937 cites W104808469 @default.
• W2041198937 cites W172441555 @default.
• W2041198937 cites W1978536869 @default.
• W2041198937 cites W1982815487 @default.
• W2041198937 cites W1996301738 @default.
• W2041198937 cites W1996996599 @default.
• W2041198937 cites W2009667073 @default.
• W2041198937 cites W2024739089 @default.
• W2041198937 cites W2033513583 @default.
• W2041198937 cites W2035596446 @default.
• W2041198937 cites W2036509876 @default.
• W2041198937 cites W2037947970 @default.
• W2041198937 cites W2053870561 @default.
• W2041198937 cites W2053978887 @default.
• W2041198937 cites W2062241953 @default.
• W2041198937 cites W2075441963 @default.
• W2041198937 cites W2082879803 @default.
• W2041198937 cites W2104502615 @default.
• W2041198937 cites W2113620026 @default.
• W2041198937 cites W2117385325 @default.
• W2041198937 cites W2136026295 @default.
• W2041198937 cites W2143963941 @default.
• W2041198937 cites W2145396879 @default.
• W2041198937 cites W2148922824 @default.
• W2041198937 cites W2160959686 @default.
• W2041198937 cites W2463712199 @default.
• W2041198937 cites W4317675717 @default.
• W2041198937 doi "https://doi.org/10.1016/s0022-5347(01)61930-x" @default.
• W2041198937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9915432" @default.
• W2041198937 hasPublicationYear "1999" @default.
• W2041198937 type Work @default.
• W2041198937 sameAs 2041198937 @default.
• W2041198937 citedByCount "49" @default.
• W2041198937 countsByYear W20411989372013 @default.
• W2041198937 countsByYear W20411989372014 @default.
• W2041198937 countsByYear W20411989372015 @default.
• W2041198937 countsByYear W20411989372016 @default.
• W2041198937 countsByYear W20411989372018 @default.
• W2041198937 countsByYear W20411989372019 @default.
• W2041198937 countsByYear W20411989372020 @default.
• W2041198937 countsByYear W20411989372021 @default.
• W2041198937 crossrefType "journal-article" @default.
• W2041198937 hasAuthorship W2041198937A5009372114 @default.
• W2041198937 hasAuthorship W2041198937A5024919772 @default.
• W2041198937 hasAuthorship W2041198937A5025890613 @default.
• W2041198937 hasAuthorship W2041198937A5082495905 @default.
• W2041198937 hasAuthorship W2041198937A5089739371 @default.
• W2041198937 hasConcept C121332964 @default.
• W2041198937 hasConcept C121608353 @default.
• W2041198937 hasConcept C126322002 @default.
• W2041198937 hasConcept C126894567 @default.
• W2041198937 hasConcept C141071460 @default.
• W2041198937 hasConcept C159110652 @default.
• W2041198937 hasConcept C168563851 @default.
• W2041198937 hasConcept C2775871022 @default.
• W2041198937 hasConcept C2776235491 @default.
• W2041198937 hasConcept C2780768273 @default.
• W2041198937 hasConcept C44838205 @default.
• W2041198937 hasConcept C62520636 @default.
• W2041198937 hasConcept C71924100 @default.
• W2041198937 hasConceptScore W2041198937C121332964 @default.
• W2041198937 hasConceptScore W2041198937C121608353 @default.
• W2041198937 hasConceptScore W2041198937C126322002 @default.
• W2041198937 hasConceptScore W2041198937C126894567 @default.
• W2041198937 hasConceptScore W2041198937C141071460 @default.
• W2041198937 hasConceptScore W2041198937C159110652 @default.
• W2041198937 hasConceptScore W2041198937C168563851 @default.
• W2041198937 hasConceptScore W2041198937C2775871022 @default.
• W2041198937 hasConceptScore W2041198937C2776235491 @default.
• W2041198937 hasConceptScore W2041198937C2780768273 @default.
• W2041198937 hasConceptScore W2041198937C44838205 @default.
• W2041198937 hasConceptScore W2041198937C62520636 @default.
• W2041198937 hasConceptScore W2041198937C71924100 @default.
• W2041198937 hasIssue "2" @default.
• W2041198937 hasLocation W20411989371 @default.
• W2041198937 hasLocation W20411989372 @default.
• W2041198937 hasOpenAccess W2041198937 @default.
• W2041198937 hasPrimaryLocation W20411989371 @default.
• W2041198937 hasRelatedWork W1967600635 @default.
• W2041198937 hasRelatedWork W2032223225 @default.
• W2041198937 hasRelatedWork W2347502955 @default.
• W2041198937 hasRelatedWork W2364684563 @default.
• W2041198937 hasRelatedWork W2383305874 @default.
• W2041198937 hasRelatedWork W2385984580 @default.
• W2041198937 hasRelatedWork W3032073005 @default.
• W2041198937 hasRelatedWork W3032098648 @default.
• W2041198937 hasRelatedWork W3124319276 @default.
• W2041198937 hasRelatedWork W4377227208 @default.

• next